Cobalt Therapeutics, LLC offers products that fit seamlessly into current clinical settings and enhance their therapeutic offerings to patients, decrease costs, and improve outcomes.
These programs have been evaluated in randomized, controlled trials
and published in leading peer-reviewed journals.
SHADE™ was developed by researcher and clinician Dr. Frances Kay Lambkin and published in the field’s leading journal: Addiction. This web based, interactive program for substance use, alcohol use and depression has received acclaim for its ability to be used over broad geographical areas as well as for its outcomes and approach.
For more information about SHADE’s awards, press coverage and impact